This review presents the advances obtained over the last 5 years in the medical/antibiotic therapy scene, with the use of products based on AMPs, as well as perspectives on the synergic effect of AMPs in association with current drugs for the treatment of bacterial infectious diseases. The gene discussed is ADSL; the disease is bacterial infectious disease.